Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Current Issues in Pharmacy and Medical Sciences
Volume 34 (2021): Issue 3 (September 2021)
Open Access
Comparative efficacy of empagliflozin versus placebo in the treatment of type 1 diabetes mellitus: a meta-analysis of randomized controlled trials
Syed Wasif Gillani
Syed Wasif Gillani
,
Anam Azhar
Anam Azhar
,
Shabaz Mohiuddin Gulam
Shabaz Mohiuddin Gulam
,
Fithawit Bahran Gebreigziabher
Fithawit Bahran Gebreigziabher
and
Hassaan Anwer Rathore
Hassaan Anwer Rathore
| Oct 08, 2021
Current Issues in Pharmacy and Medical Sciences
Volume 34 (2021): Issue 3 (September 2021)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Oct 08, 2021
Page range:
123 - 129
Received:
Jan 06, 2021
Accepted:
Jun 12, 2021
DOI:
https://doi.org/10.2478/cipms-2021-0024
Keywords
meta-analysis
,
type 1 diabetes
,
empagliflozin
,
placebo
,
evidence-based practice
© 2021 Syed Wasif Gillani et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.